Virtu Financial LLC Takes Position in STRATA Skin Sciences Inc (SSKN)

Virtu Financial LLC acquired a new position in shares of STRATA Skin Sciences Inc (NASDAQ:SSKN) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 13,517 shares of the medical device company’s stock, valued at approximately $39,000.

A number of other large investors have also recently made changes to their positions in the business. Northern Trust Corp bought a new stake in STRATA Skin Sciences during the 4th quarter worth about $36,000. Acadian Asset Management LLC increased its stake in shares of STRATA Skin Sciences by 79.3% in the 4th quarter. Acadian Asset Management LLC now owns 32,568 shares of the medical device company’s stock valued at $85,000 after acquiring an additional 14,408 shares during the last quarter. Creative Planning increased its stake in shares of STRATA Skin Sciences by 75.0% in the 4th quarter. Creative Planning now owns 35,000 shares of the medical device company’s stock valued at $91,000 after acquiring an additional 15,000 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of STRATA Skin Sciences by 70.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 66,813 shares of the medical device company’s stock valued at $237,000 after acquiring an additional 27,586 shares during the last quarter. Finally, Nantahala Capital Management LLC increased its stake in shares of STRATA Skin Sciences by 8.2% in the 4th quarter. Nantahala Capital Management LLC now owns 2,768,001 shares of the medical device company’s stock valued at $7,197,000 after acquiring an additional 209,110 shares during the last quarter. 28.25% of the stock is owned by hedge funds and other institutional investors.

Shares of SSKN stock opened at $2.68 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 4.54 and a quick ratio of 4.03. The stock has a market capitalization of $80.25 million, a PE ratio of 1.36 and a beta of 1.25. STRATA Skin Sciences Inc has a one year low of $1.36 and a one year high of $3.88.

Separately, ValuEngine cut STRATA Skin Sciences from a “buy” rating to a “hold” rating in a research note on Monday, April 1st. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $4.92.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.baseballdailydigest.com/news/2019/05/04/virtu-financial-llc-takes-position-in-strata-skin-sciences-inc-sskn.html.

STRATA Skin Sciences Profile

STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.

Featured Article: How to Use the New Google Finance Tool

Want to see what other hedge funds are holding SSKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STRATA Skin Sciences Inc (NASDAQ:SSKN).

Institutional Ownership by Quarter for STRATA Skin Sciences (NASDAQ:SSKN)

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.